PUBLICATIONS · 2536911
A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Obstet Gynecol
- Publication date
- 1989 Mar
- First author
- Curry SL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Curry SL
- type
- Author
- name
- Blessing JA
- type
- Author
- name
- DiSaia PJ
- type
- Author
- name
- Soper JT
- type
- Author
- name
- Twiggs LB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Curry SL
- type
- Author
- name
- Blessing JA
- type
- Author
- name
- DiSaia PJ
- type
- Author
- name
- Soper JT
- type
- Author
- name
- Twiggs LB
- type
- Author
- bibliography ids
- nci-bib-dc3520f8a178ac019a630dfb
- book metadata
- content sha256
- d7b58647c4dac257644cc2ebfdba9ac588e92b4aad224fcfe10b3a8d3abcdd14
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:2536911
- immutable id
- pubmed:2536911@d7b58647c4dac257644cc2ebfdba9ac588e92b4aad224fcfe10b3a8d3abcdd14
- journal
- abbreviation
- Obstet Gynecol
- issn electronic
- Source null
- issn print
- 0029-7844
- issue
- 3 Pt 1
- name
- Obstetrics and gynecology
- nlm unique id
- 0401101
- pages
- 357-62
- volume
- 73
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 2536911
- provenance
- batch id
- a200ed3d3f0da2c0bb77
- provider
- NCBI PubMed ESummary
- record sha256
- 8050fe540ec37fdb284f4bb4b1abf4846f856d105ae1525433cd8a52678f84a7
- response sha256
- fca9a34da948816f71802a739926070ea93d0f46ed836320bb1feb42dde1561e
- retrieved at
- 2026-09-09T23:45:10.684024+00:00
- publication date
- display
- 1989 Mar
- precision
- month
- year
- 1989
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/2536911/
- title
- A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Preserved source evidence · Not medical advice
Triangle